Clinical Study

Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study

Table 3

Logistic regression models for “disease active” status.

OutcomeRisk factorsUnivariate analysisMultivariable analysis
Odds (95% CI) valueOdds (95% CI) value

Disease active:
recurrent or
further dysplasia,
malignant
transformation, and OSCC
development
Age1.007 (0.976–1.040)0.646
Sex
 FemalesReference category
 Males1.448 (0.806–3.455)0.405
Leukoplakia types
 HomogenousReference category
 Nonhomogenous2.991 (1.160–7.713)0.0233.319 (0.799–13.779)0.099
PMDs site
 FOMReference category
 Tongue3.381 (1.292–8.845)0.0133.323 (0.775–14.241)0.106
 Other remaining sites2.893 (0.971–8.620)0.0570.944 (0.171–5.218)0.947
Histopathology (WHO grading)
 Mid dysphasiaReference category
 Moderate 1.129 (0.350–3.641)0.8391.960 (0.419–9.167)0.393
 Severe4.622 (1.527–13.990)0.0075.994 (1.282–28.018)0.023
 CIS4.800 (1.123–20.479)0.03417.104 (2.427–120.561)0.004
Binary grading
 Low gradeReference category
 High grade2.828 (1.182–6.678)0.020
Resection margin
 Free marginsReference category
 Dysplastic margins 2.812 (1.073–7.371)0.0356.562 (1.545–27.878)0.011
PMDs size (mm2)
 Minor < 200Reference category
 Intermediate 200–6002.327 (0.944–5.740)0.067
 Major > 6004.464 (1.035–18.394) 0.045